Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: borredo

I agree, that long term that could/will be problematic if we do not create a measured and predicted revenue stream. That is why I included the following statement: 

"I say short term because I don't know where our current management can take this company beyond the MMP, IMO it is too early to tell."

IMO, in the short term, if we can create a cadence of predictable $$$ licensees than our P/E ratio could get much higher than it is today, possibly equivalent to ARM's. What we do with the money will determine our future P/E ratio and our place in this sector. JMO Time will tell. Hope things are good for you. Good luck to you, me, us, and all longs.

 

Share
New Message
Please login to post a reply